Alzheimer’s care is advancing, from new treatments that can slow cognitive decline to blood-based tests that can help identify the disease earlier. Policy discussions are underway around how to expand access, including the bipartisan ASAP Act, which would create a pathway for Medicare coverage of blood-based tests used to detect Alzheimer’s before symptoms appear.